Question · Q4 2025
Frank Mitsch questioned the timing of initiating a strategic review for a company sale, assuming 2026 is the bottom of the cycle, and asked why not wait until restructuring yields tangible results to potentially achieve better shareholder value.
Answer
Pierre Brondeau, Chairman, CEO and President, confirmed that 2026 is expected to be the bottom, with growth returning in 2027-2028 under the base plan. He explained that the strategic review is a board decision to explore a parallel path for maximizing shareholder value. He noted that a different ownership might offer more financial flexibility to accelerate growth, especially for new active ingredients, compared to the current need to fund restructuring. He stressed that while the 2026 plan is robust, the alternative could be highly beneficial.
Ask follow-up questions
Fintool can predict
FMC's earnings beat/miss a week before the call

